According to the American Society of Interventional Pain Physicians, the United States consumes roughly 80% of the world's opioids. According to a May 2015 article published in the American Gastroenterological Association, chronic constipation affects one in every six people in the United States and is the third-leading cause of outpatient clinic visits. It is especially common in obese women.
Europe's high-acuity information system, high disposable income level, and widespread adoption of unhealthy lifestyles make it a potentially high-growth Personalized Cell Therapy Market. Asia Pacific is also expected to be a lucrative market for constipation treatment, owing to the region's increasing westernisation, as evidenced by the region's increased adoption of non-nutritious fast food.
Read More:
https://knackersblogger.blogspot.com/2022/12/personalized-cell-therapy-market-size.html
